493 related articles for article (PubMed ID: 31147443)
1. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
Guengerich FP; Wilkey CJ; Phan TTN
J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
[TBL] [Abstract][Full Text] [Related]
2. Conformational selection dominates binding of steroids to human cytochrome P450 17A1.
Guengerich FP; Wilkey CJ; Glass SM; Reddish MJ
J Biol Chem; 2019 Jun; 294(26):10028-10041. PubMed ID: 31072872
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil.
Tracy TS; Korzekwa KR; Gonzalez FJ; Wainer IW
Br J Clin Pharmacol; 1999 May; 47(5):545-52. PubMed ID: 10336579
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
5. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
Hosea NA; Miller GP; Guengerich FP
Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4.
Isin EM; Guengerich FP
J Biol Chem; 2006 Apr; 281(14):9127-36. PubMed ID: 16467307
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome
Kim D; Kim V; Tateishi Y; Guengerich FP
Drug Metab Dispos; 2021 Oct; 49(10):902-909. PubMed ID: 34330716
[TBL] [Abstract][Full Text] [Related]
8. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5.
Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R
J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214
[TBL] [Abstract][Full Text] [Related]
9. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
10. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
Yamazaki H; Shimada T
Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes.
Bellec G; Dréano Y; Lozach P; Ménez JF; Berthou F
Carcinogenesis; 1996 Sep; 17(9):2029-34. PubMed ID: 8824531
[TBL] [Abstract][Full Text] [Related]
13. Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: STRUCTURE OF THE ENZYME·PROGESTERONE SUBSTRATE COMPLEX AND RATE-LIMITING C-H BOND CLEAVAGE.
Pallan PS; Wang C; Lei L; Yoshimoto FK; Auchus RJ; Waterman MR; Guengerich FP; Egli M
J Biol Chem; 2015 May; 290(21):13128-43. PubMed ID: 25855791
[TBL] [Abstract][Full Text] [Related]
14. Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation.
Kudo S; Odomi M
Eur J Clin Pharmacol; 1998 May; 54(3):253-9. PubMed ID: 9681669
[TBL] [Abstract][Full Text] [Related]
15. Induced Fit Describes Ligand Binding to Membrane-Associated Cytochrome P450 3A4.
Sweeney DT; Zárate-Pérez F; Stokowa-Sołtys K; Hackett JC
Mol Pharmacol; 2023 Oct; 104(4):154-163. PubMed ID: 37536953
[TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of lauric acid hydroxylation by human cytochrome P450 4A11.
Kim D; Cha GS; Nagy LD; Yun CH; Guengerich FP
Biochemistry; 2014 Oct; 53(39):6161-72. PubMed ID: 25203493
[TBL] [Abstract][Full Text] [Related]
18. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
19. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes.
Clarke SE; Baldwin SJ; Bloomer JC; Ayrton AD; Sozio RS; Chenery RJ
Chem Res Toxicol; 1994; 7(6):836-42. PubMed ID: 7696540
[TBL] [Abstract][Full Text] [Related]
20. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
